🟢 Context Therapeutics is trading 8.25% up in after-hours trading with no clear catalyst identified

Context Therapeutics is trading at $0.21, up 8.25% in after-hours trading, with no clear company-specific catalyst identified.

• The stock closed the November 3 regular session at $0.19.
• Available news listings show the September 9 CT-202 trial update as the latest company release.
• Q3 earnings were listed for November 11, not November 3; the supplied market context does not establish a direct explanation for the after-hours gain.